The third progress meeting of the NeuroCOV project took place on June 17–18, 2025, at Klaus K Hotel in Helsinki, Finland, hosted by the team from the University of Helsinki. The meeting was held in a hybrid format, allowing for both in-person and rem...

Professor Ine Van Hoyweghen, from the Faculty of Social Sciences at KU Leuven and a valued member of the EU-funded NeuroCOV project, has been awarded the 2025 Francqui Prize for Human Sciences. Widely regarded as the Belgian equivalent of the Nobel...

On March 11, 2020, the WHO declared COVID-19 a pandemic, giving the world a term for what was unfolding—yet leaving countless uncertainties in communities, countries, and lives across the globe. Five years later, many questions remain: Is it truly ov...

On June 25th, NeuroCOV partner Human Technopole hosted their first PhD symposium. The event provided PhD students and postdocs with the opportunity to share their work with the institution community through a poster or a talk. One of NeuroCOV’s PhD s...

Berlin, Germany - 30 May 2024 The recent approval of the European Health Data Space (EHDS) by the European Parliament at the end of April marked a significant milestone for the European health domain. The EHDS is bound to transform healthcare delive...

The Regulation on the European Health Data Space (EHDS) is bound to have a transformative impact on the health domain in Europe, (re)shaping healthcare delivery and research and innovation activities across the EU. Driven by a vision of harmonising...

This year’s NeuroCOV progress meeting took place May 13th-14th, 2024, at KU Leuven, Belgium. The meeting was held in a hybrid format, with most attendees joining in person.

The meeting began with updates from all work package (WP) leaders on the...

People with post-COVID syndrome (PCS) following the COVID-19 infection often suffer from intense fatigue and dyspnea. This is what emerges from a new Nordic study led by Umeå University and recently published in the BMJ Public Health journal. High bl...

Long-term complications of COVID-19 on the brain are recognised in patients across all age groups and independent of infection severity. Symptoms of such neurological deficits are diverse and include concentration problems, memory lapses, brain scan...

Prof. Giuseppe Testa's laboratory at the Human Technopole (HT) in Milan is hiring a Postdoctoral Researcher to contribute to the NeuroCOV project. To learn more and apply, please click here.
Application closing date: 1st of September 2023

On the 26th and 27th of June, 2023, the first NeuroCOV Progress Meeting took place at Human Technopole in Milan. Following last year’s hybrid Kick-Off Meeting, this was the first time the majority of the Consortium was able to meet in person.

All...

Join stakeholders and policymakers at the EU Knowledge Valorisation Week between 25 April and 28 April 2023. The annual event highlights best practices promoting the uptake of research results and science-based solutions for all.

This year, the eve...

In the issue of March 2023, the magazine PLATINUM “Aziende & Protagonisti”, attached to the Italian financial newspaper Il Sole 24 Ore, features a one-page article on NeuroCOV under the section dedicated to “Research & Innovation”. In this interv...

NeuroCOV invites anyone involved in the field of Artificial Intelligence in medical technology to join the webinar on patent protection on the 16th of March 2023.

The webinar is organised by the European Patent Office in cooperation with the Europe...

Oliver Harschnitz's laboratory at the Human Technopole (HT) in Milan is hiring a Postdoctoral Researcher to contribute to the NeuroCOV project. To learn more and apply, please visit https://careers.humantechnopole.it/o/postdoc-harschnitz-group-neuro...

Prof. Giuseppe Testa's laboratory at the Human Technopole (HT) in Milan is hiring a Postdoctoral Researcher to contribute to the NeuroCOV project. To learn more and apply, please visit: https://careers.humantechnopole.it/o/postdoc-testa-group-eu-pro...

New EU Research Project NEUROCOV Investigates Neurological and Neuropsychiatric Complications Following COVID-19 Infections

Over the next five years, the interdisciplinary NEUROCOV consortium will investigate the role of the host-virus interplay in...